Cite
Identification of a novel class of cortisol biosynthesis inhibitors and its implications in a therapeutic strategy for hypercortisolism
MLA
Soo Hyun Kim, et al. “Identification of a Novel Class of Cortisol Biosynthesis Inhibitors and Its Implications in a Therapeutic Strategy for Hypercortisolism.” Life Sciences, vol. 325, July 2023, p. 121744. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ef8953db2698c51e05ea3efb5d012ada&authtype=sso&custid=ns315887.
APA
Soo Hyun Kim, Gi Hoon Son, Joo Young Seok, Sung Kook Chun, Hwayoung Yun, Jaebong Jang, Young-Ger Suh, Kyungjin Kim, Jong-Wha Jung, & Sooyoung Chung. (2023). Identification of a novel class of cortisol biosynthesis inhibitors and its implications in a therapeutic strategy for hypercortisolism. Life Sciences, 325, 121744.
Chicago
Soo Hyun Kim, Gi Hoon Son, Joo Young Seok, Sung Kook Chun, Hwayoung Yun, Jaebong Jang, Young-Ger Suh, Kyungjin Kim, Jong-Wha Jung, and Sooyoung Chung. 2023. “Identification of a Novel Class of Cortisol Biosynthesis Inhibitors and Its Implications in a Therapeutic Strategy for Hypercortisolism.” Life Sciences 325 (July): 121744. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ef8953db2698c51e05ea3efb5d012ada&authtype=sso&custid=ns315887.